Analysis
PublicGLAXOSMITHKLINE LLC holds $2.8B across 206 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 75A50122D00002. Recompete timing centers on the Dec 31, 2027 PoP end — agencies typically plan 12–18 months ahead.
Contract facts
FederalNo full NAICS 541714 intel page yet. Browse NAICS intelligence
PURPOSE OF THIS MODIFICATION IS TO: 1. ACCEPT TRANSFER ACCOUNTABILITY OF 5,015,690 VIALS (50.1 MILLION DOSES) OF AS03 ADJUVANT FROM CONTRACT # W15QKN-20-C-0048 TO CONTRACT # 75A50122D00002 2. ADD FUNDING IN THE AMOUNT OF $1,038,708.00 FOR 33 BUL
Recompete timing
PublicCurrent PoP ends Dec 31, 2027 (501 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Jul 1, 2026.
Watch this contract — one email →Incumbent footprint
Public recordGLAXOSMITHKLINE LLC — $2.8B obligated across 206 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Track this contract
Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open GLAXOSMITHKLINE LLC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Frequently asked questions
What is contract 75A50123F61005?
75A50123F61005 (PURPOSE OF THIS MODIFICATION IS TO: 1. ACCEPT TRANSFER ACCOUNTABILITY OF 5,015,690 VIALS (50.1 MILLION DOSES) OF AS03 A…) is a Department of Health and Human Services (HHS) award with an estimated value of $171.6M, currently held by GLAXOSMITHKLINE LLC. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.
Who is the incumbent on 75A50123F61005?
GLAXOSMITHKLINE LLC is the incumbent with $2.8B across 206 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2027.
When does 75A50123F61005 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →